Antithrombotic therapy and out- comes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial. Eur Heart J. 2009;30:2019 28. 498. Gao R, Zhang J, Cheng L, et al. A Phase II, randomized, double-blind, multicenter, based on standard therapy, placebo-controlled study of the efficacy and safety of recombinant human neuregulin-1 in patients with chronic heart failure. J Am Coll Cardiol. 2010;55:1907 14. 499. Califf RM, White HD, Van de Werf F, et al; GUSTO-I Investigators. One-year results from the Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries (GUSTO-I) trial. Circulation. 1996;94:1233 8. 500. Bloch Thomsen PE, Jons C, Raatikainen MJP, et al. Long-term recording of cardiac arrhythmias with an implantable cardiac monitor in patients with reduced ejection fraction after acute myocardial infarction: the Car- diac Arrhythmias and Risk Stratification After Acute Myocardial Infarc- tion (CARISMA) study. Circulation. 2010;122:1258 64. 501. Fuster V, Ryd n LE, Cannom DS, et al. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the Ameri- can College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in partnership with the European Society of Cardiology. Circulation. 2011;123:e269 367. 502. Camm AJ, Kirchhof P, Lip GYH, et al. Guidelines for the manage- ment of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010;31:2369 429. Erratum in: Eur Heart J. 2011;32:1172. 503. Deleted in press. 504. Neumar RW, Otto CW, Link MS, et al. Part 8: adult advanced cardio- vascular life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2010;122:S729-67. Erratum in: Circulation. 2011;123:e236. 505. 